Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment. Take 2 mins to learn more.

News & Insights

News - 24th February 2025

OrganOx Announces $142 Million Equity Financing Led by HealthQuest Capital

  • OrganOx has completed a $142m primary and secondary equity financing to accelerate the rollout of its metra devices.
  • The oversubscribed round was led by external investor HealthQuest, alongside new investors Sofina, Soleus Capital, and Avidity Partners and with support from existing investors BGF and Lauxera Capital Partners.
Read post

News - 30th May 2024

The Lancet publishes results of a landmark clinical study that supports the ability of Caristo’s CaRi-Heart® AI technology to quantify coronary artery inflammation and accurately predict cardiac events.

  • Leading medical journal, The Lancet, has published the findings of the 40,000 patient ORFAN study demonstrating the ability of Caristo’s CaRi-Heart FAI-Score to predict fatal and non-fatal cardiac events.
  • Caristo’s AI-Risk model, CaRi-Heart Risk Score, outperformed other scores in routine clinical use for prediction of cardiac mortality, and when presented to clinicians, resulted in changes of management decision in 45% of the patients.
Read post

News - 3rd April 2024

Oxford Technology & Innovations EIS Fund (OTIF) has subscribed to Biofidelity’s $24m funding round.

  • Biofidelity has raised an internally led $24m funding round with support from existing investors including Agilent Technologies, Octopus Ventures, BlueYard Capital, and Longwall Ventures.
  • The funding will support commerical rollout following the launch of its first product ASPYRE-Lung, a novel test that simplifies and accelerates the detection of biomarkers for non-small cell lung cancer.
Read post

News - 27th November 2023

Oxford Quantum Circuits launches OQC Toshiko, the world’s first enterprise ready quantum platform alongside announcement of its ongoing $100m Series B funding round.

  • OQC has announced its ongoing $100m Series B, led by Japanese venture capital fund SBI Investment, in addition to existing investors Oxford Science Enterprises (OSE), University of Tokyo Edge Capital Partners (UTEC), and Lansdowne Partners.
  • The announcement is made alongside the launch of OQC Toshiko the Company’s powerful next generation 32-qubit platform, deployed to commercial data-centres, enabling businesses to tap into ground-breaking technology from anywhere in the world, seamlessly and securely.
Read post